Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Special considerations for the adolescent with obesity: An obesity medicine association (OMA) clinical practice statement (CPS) 2024.Obesity pillars · 2024
   Article
2. Glucagon-like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth.TouchREVIEWS in endocrinology · 2023
   Review
3. Metabolic, behavioral health, and disordered eating comorbidities associated with obesity in pediatric patients: An Obesity Medical Association (OMA) Clinical Practice Statement 2022.Obesity pillars · 2022
   Article
4. Further RISE'ing to the Challenge of Type 2 Diabetes in Youth.Diabetes care · 2021
   Article
5. Body Mass Index and Its Change from Adolescence to Adulthood Are Closely Related to the Risk of Adult Metabolic Syndrome in China.International journal of endocrinology · 2021
   Article
6. The Continuing Evolution of Precision Health in Type 2 Diabetes: Achievements and Challenges.Current diabetes reports · 2019
   Review
7. Exercise Adherence in Hispanic Adolescents with Obesity or Type 2 Diabetes.Journal of pediatric nursing
   Article

Corrections and comments

• Comment on
  Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic Clamp.2018
• Comment on
  Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: II. Observations Using the Oral Glucose Tolerance Test.2018
• Comment on
  Impact of Insulin and Metformin Versus Metformin Alone on β-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.2018

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as